Monico-Ramos R, Ochoa-Flores M, Hernández-Herrera RJ, Flores-Pompa E

Language: Spanish
References: 11
Page: 351-357
PDF size: 312.87 Kb.

ABSTRACT

Introduction: the leading cause of fetal anemia is Rh isoimmunization. The timely diagnosis by ultrasound and intravascular transfusion improves the prognosis.
Objective: to evaluate the increase in hemoglobin in the fetus and correlate the red cell transfusion volume with elevation of hemoglobin and perinatal outcome.
Patients and methods: prospective, case series study. We included 17 patients with fetal anemia detected by measuring the peak systolic velocity of middle cerebral artery and determination of fetal hemoglobin before and after cordocentesis. After confirmation of fetal anemia (Hb ‹10 g/dL), was held fetal transfusion with 50 mL/kg estimated fetal weight, with packed red blood cells type O Rh negative.
Results: In 17 cases fetal anemia was diagnosed, of which 11 (64%) had Rh isoimmunization and 6 (36%) were not immune. The 17 cases received 27 intravascular transfusions, in 75% hemoglobin rose to 10 g/dL, 45% in the first transfusion, 25% in the second and 10% in the third transfusion. Fetal hemoglobin between before and after transfusion was 6.5 and 12.9 g/dl, respectively (p‹0.001) and allowed to continue the pregnancy from 3 to 12 weeks from the first transfusion. There were 4 deaths (2 stillbirths and 2 neonatal), but only one was related to the procedure. the survival rate was 76%, mortality in the presence of hydrops was 30% and no deaths in patients without hydrops.
Conclusions: Mortality in fetal anemia was 23.6% and only one case was related to intravascular transfusion. In cases of survival to birth, pregnancy lasted ‹30 weeks gestation. Hemoglobin rose from 27 to 300% of the initial fetal hemoglobin. The presence of fetal hydrops significantly increases mortality.

REFERENCES

1. Giancarlo M. Middle cerebral artery peak systolic velocity. Is it the standard of care for the diagnosis of fetal anemia? J Ultrasound Med 2005;24:697-702.

2. González F, Paravisini I, Morales J, et al. Transfusión intrauterina intravascular. Rev Obst Ginecol Venez 2006;66:67-73.

3. Giancarlo M. Noninvasive diagnosis by Doppler ultrasonography of fetal anemia due to maternal red cell alloimmunization. N Engl J Med 2000;342:0-14

4. Segata M, Giancarlo M. Fetal Anemia: new technologies. Curr Opin Obstet Gynecol 2004;16:153-8.

5. Ochoa-Torres MA, Hernández-Herrera RJ, Luna-García SA, Forsbach G. Ultrasonido Doppler para la detección de anemia fetal por isoinmunización a Rh. Rev Med Inst Mex Seguro Soc 2007;45:215-220.

6. Utter GO, Socol ML, Dooley SL, MacGregor SN, Millard DD. Is intrauterine transfusion associated with diminished fetal growth? Am J Obstet Gynecol 1990;6:1781-1784.

7. Radunovic N, Lockwood CJ, Alvarez M, Plecas D, Chitkara U, Berkowitz RL. The severity anemic and hydrops isoinmune fetus: changes in fetal hematocrit associated with intrauterine death. Obstet Gynecol. 1992 Mar;79:390-3.

8. Grannum PA, Copel JA, Plaxe SC, Scioscia AL, Hobbins JC. In utero exchance transfusion by direct intravascular injection in severe erythroblastosis fetalis. N Engl J Med. 1986;314:1431-1434.

9. Craparo FJ, Bonati F, Gementi P, Nicolini U. The effects of serial intravascular transfusions in ascetic/hydropic RhD-alloimmunized fetuses. Ultrasound Obstet Gynecol 2005;25:144-148.

10. Borrell A, Pereira A, Fortuny A, Martinez JM, Puerto V, Borobio V, et al. Transfusion intravascular fetal en el tratamiento de la isoinmunización. Progresos de Obstetricia y Ginecologìa 2005;48(4):179-185.

11. Farina A, Calderoni P, Simonazzi G, Carinci P, Rizzo N. Survival analysis of transfused fetuses affected by Rh-alloimmunization. Prenat Diagn 2000;20:881-885.